DAWN
Price
$12.43
Change
+$0.20 (+1.64%)
Updated
Feb 21 closing price
Capitalization
1.25B
2 days until earnings call
SLNO
Price
$46.13
Change
-$1.29 (-2.72%)
Updated
Feb 21 closing price
Capitalization
1.99B
30 days until earnings call
Ad is loading...

DAWN vs SLNO

Header iconDAWN vs SLNO Comparison
Open Charts DAWN vs SLNOBanner chart's image
Day One Biopharmaceuticals
Price$12.43
Change+$0.20 (+1.64%)
Volume$758.3K
Capitalization1.25B
Soleno Therapeutics
Price$46.13
Change-$1.29 (-2.72%)
Volume$352.73K
Capitalization1.99B
DAWN vs SLNO Comparison Chart
Loading...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DAWN vs. SLNO commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAWN is a Hold and SLNO is a Buy.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (DAWN: $11.93 vs. SLNO: $48.07)
Brand notoriety: DAWN and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DAWN: 85% vs. SLNO: 83%
Market capitalization -- DAWN: $1.25B vs. SLNO: $1.99B
DAWN [@Biotechnology] is valued at $1.25B. SLNO’s [@Biotechnology] market capitalization is $1.99B. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DAWN’s FA Score shows that 0 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • DAWN’s FA Score: 0 green, 5 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, DAWN is a better buy in the long-term than SLNO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DAWN’s TA Score shows that 2 TA indicator(s) are bullish while SLNO’s TA Score has 5 bullish TA indicator(s).

  • DAWN’s TA Score: 2 bullish, 5 bearish.
  • SLNO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SLNO is a better buy in the short-term than DAWN.

Price Growth

DAWN (@Biotechnology) experienced а +0.08% price change this week, while SLNO (@Biotechnology) price change was -2.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.27%. For the same industry, the average monthly price growth was +3.99%, and the average quarterly price growth was +2.35%.

Reported Earning Dates

DAWN is expected to report earnings on May 07, 2025.

SLNO is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($1.99B) has a higher market cap than DAWN($1.25B). SLNO YTD gains are higher at: 6.941 vs. DAWN (-5.841). SLNO has higher annual earnings (EBITDA): -136.5M vs. DAWN (-210.08M). DAWN has more cash in the bank: 558M vs. SLNO (257M). DAWN has less debt than SLNO: DAWN (2.62M) vs SLNO (3.03M). DAWN has higher revenues than SLNO: DAWN (102M) vs SLNO (0).
DAWNSLNODAWN / SLNO
Capitalization1.25B1.99B63%
EBITDA-210.08M-136.5M154%
Gain YTD-5.8416.941-84%
P/E RatioN/AN/A-
Revenue102M0-
Total Cash558M257M217%
Total Debt2.62M3.03M86%
FUNDAMENTALS RATINGS
SLNO: Fundamental Ratings
SLNO
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DAWNSLNO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 6 days ago
84%
Bearish Trend 6 days ago
88%
Momentum
ODDS (%)
Bearish Trend 6 days ago
79%
Bearish Trend 6 days ago
85%
MACD
ODDS (%)
Bearish Trend 6 days ago
82%
Bearish Trend 6 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
84%
Bearish Trend 6 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
81%
Bearish Trend 6 days ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 19 days ago
85%
Declines
ODDS (%)
Bearish Trend 21 days ago
81%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
N/A
Bullish Trend 6 days ago
90%
Aroon
ODDS (%)
Bearish Trend 6 days ago
85%
Bullish Trend 6 days ago
90%
View a ticker or compare two or three
Ad is loading...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

DAWN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with DNLI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAWN
1D Price
Change %
DAWN100%
-2.69%
DNLI - DAWN
44%
Loosely correlated
+1.97%
ACLX - DAWN
42%
Loosely correlated
-1.49%
NRIX - DAWN
40%
Loosely correlated
-4.89%
SLNO - DAWN
40%
Loosely correlated
-2.24%
AVTE - DAWN
38%
Loosely correlated
-3.27%
More

SLNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with KYMR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
-2.24%
KYMR - SLNO
43%
Loosely correlated
+0.68%
XENE - SLNO
41%
Loosely correlated
+0.62%
SVRA - SLNO
40%
Loosely correlated
+1.06%
GRCE - SLNO
38%
Loosely correlated
-0.87%
PTGX - SLNO
38%
Loosely correlated
-2.38%
More